🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Approximately 225 patients meeting study entry requirements will be enrolle...
Status
Withdrawn
Location
Multiple Locations
Start Date
2008-11
Trial ID
NCT00752999
Treatments Being Tested
Patients: B-cell lymphoma, refractory, diffuse, nodular, mantle, other Phas...
Status
Completed
Location
Research Site
Start Date
2007-04
Trial ID
NCT00446095
Treatments Being Tested
The purpose of this study is to determine whether the Spleen Tyrosine Kinas...
Status
Completed
Location
Divison of Rheumatology Allergy and Immunology
Start Date
2008-05
Trial ID
NCT00665925
Treatments Being Tested
This is a Phase II, multicenter, randomized, double-blind, placebo-controll...
Status
Completed
Location
Pacific Arthritis Center Medical Group
Start Date
2006-08
Trial ID
NCT00326339
The purpose of this study is to determine whether Fostamatinib Disodium is ...
Status
Completed
Location
Research Site
Start Date
2007-01
Trial ID
NCT00706342
Treatments Being Tested
The purpose of this study is to determine whether fostamatinib is safe and ...
Status
Completed
Location
Arizona Oncology Associates
Start Date
2014-07-14
Trial ID
NCT02076399
Treatments Being Tested
The purpose of this study is to determine whether fostamatinib is safe and ...
Status
Completed
Location
Stanford University Medical
Start Date
2014-10
Trial ID
NCT02112838
Treatments Being Tested
C-935788-055 is an open-label, multi-center, expanded access (EAP) study....
Status
No Longer Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT03363334
Treatments Being Tested
The primary objective of this study was to assess the long term safety of f...
Status
Completed
Location
Arizona Oncology Associates
Start Date
2014-10
Trial ID
NCT02077192
Treatments Being Tested
Phase 2, multi-center, open label extension study to evaluate 2 dose regime...
Status
Withdrawn
Location
Multiple Locations
Start Date
2015-09
Trial ID
NCT02433236
Treatments Being Tested